Cancer costs UK businesses £1.6bn in absences

15 weeks taken off in employees’ cancer journey

Cameron Roberts
clock • 1 min read

Cancer support service firm, Reframe Cancer, conducted research that shows absences due to cancer will cost UK business £1.6 billion in 2024.

The research, that spoke to 500 UK employees with cancer, uncovered that the average employee will be absent from work for 15 weeks. This time off includes: Pre-diagnosis worries and symptoms: 12 days Diagnosis and testing: 16 days Treatment: 24 days Recovery: 23 days The research also showed the point at which employees told their employer, 55% told their employer after their cancer diagnosis was been confirmed; 18% disclose when undergoing tests; and 11% wait until they are undergoing treatment or when treatment has finished. Mark Stephenson, CEO, Reframe Cancer, said: "...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual PMI

Trust in PMI growing

Trust in PMI growing

Fairer Finance data

Cameron Roberts
clock 17 December 2024 • 2 min read
Support for children growing over three years

Support for children growing over three years

57% uptick in treatments

Cameron Roberts
clock 05 November 2024 • 1 min read
National Friendly marks one year with Healix Health

National Friendly marks one year with Healix Health

Partnership anniversary

Cameron Roberts
clock 07 October 2024 • 1 min read